Toxic Epidermal Necrolysis from suspected Mycoplasma pneumoniae infection

Andrew J McDermott1, Bradley M Taylor, Kevin M Bernstein

  • 1Family Medicine Department, Naval Hospital Pensacola, 6000 West Highway 98, Pensacola, FL 32512, USA.

Military Medicine
|September 6, 2013
PubMed
Abstract

Insights

Mycoplasma pneumoniae infection can cause Toxic Epidermal Necrolysis (TEN), a severe skin reaction. This case highlights infection as a potential trigger for TEN, distinct from typical medication causes.

Area of Science:

  • Dermatology
  • Infectious Diseases
  • Immunology

Background:

  • Toxic Epidermal Necrolysis (TEN) and Stevens-Johnson Syndrome (SJS) are severe mucocutaneous reactions.
  • Medications are the most common cause of SJS/TEN.
  • Mycoplasma pneumoniae is a known cause of SJS, but its role in TEN is less understood.

Observation:

  • A 19-year-old male presented with pneumonia-like symptoms and a rapidly progressing, diffuse bullous rash with mucosal involvement.
  • Antibiotics were initiated but discontinued within 24 hours due to rash onset.
  • Histopathology confirmed TEN, with positive Mycoplasma antibodies and cold agglutinins.

Findings:

  • The patient's presentation and rash onset timing (less than 14 days) were consistent with an infectious etiology.
  • Mycoplasma pneumoniae infection was identified as the likely cause of TEN in this case.
  • This contrasts with the typical >14-day onset associated with drug-induced SJS/TEN.

Implications:

  • Mycoplasma pneumoniae should be considered as a potential cause of TEN, not just SJS.
  • This case expands the understanding of infectious triggers for severe mucocutaneous reactions.
  • Early recognition of infectious causes is crucial for appropriate management of SJS/TEN spectrum disorders.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...